Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 1/20 | 0.42 |
| ▸ | RXRA | P19793 | 1/20 | 0.37 |
| ▸ | RXRB | P28702 | 1/20 | 0.37 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.36 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.35 |
| ▸ | BRD4 | O60885 | 1/20 | 0.35 |
| ▸ | FEN1 | P39748 | 1/20 | 0.35 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | NR4A2 | P43354 | 2/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | AXL | P30530 | 1/20 | 0.32 |
| ▸ | SERPINE1 | P05121 | 1/20 | 0.31 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23919577 | 0.80 | MAOB (0.35) | MAOBRXRARXRBLIMK1NPC1 | |
| SCHEMBL23919689 | 0.79 | GPR3 (0.43) | L3MBTL1HSD17B10HPGD | |
| SCHEMBL25507580 | 0.78 | MAOB (0.38) | MAOBRXRARXRBLIMK1GRM2 | |
| SCHEMBL23920094 | 0.78 | MAOB (0.38) | MAOBRXRARXRBLIMK1GRM2 | |
| SCHEMBL25507283 | 0.78 | NR1H3 (0.37) | NPC1RAB9AL3MBTL1 | |
| SCHEMBL23920136 | 0.78 | MAOB (0.34) | MAOBLIMK1 | |
| SCHEMBL25477851 | 0.77 | SRD5A1 (0.33) | MAOBLIMK1L3MBTL1MAPK14 | |
| SCHEMBL23919703 | 0.77 | MAOB (0.32) | MAOBRXRARXRBGRM2 | |
| SCHEMBL23920173 | 0.77 | MAOB (0.34) | MAOBLIMK1 | |
| SCHEMBL23920065 | 0.75 | MAOB (0.39) | MAOBRXRARXRBLIMK1GRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230159567-A1 | ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-05-25 | — | — | US | disclosed |
| US-20230159567-A1 | ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-05-25 | — | — | US | disclosed |
| EP-3892704-B1 | ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO LTD (KR) | 2023-05-17 | — | — | EP | disclosed |
| EP-3892704-A1 | ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES | cynora GmbH (DE) | 2021-10-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230159567-A1 | ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES | OR10J3, OXER1, OXSR1 | MAOB 1650/4885RXRA 717/4885RXRB 504/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.